| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 36415 |
Collection of venous blood by venipuncture |
15,504 |
11,314 |
$655K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,341 |
2,296 |
$218K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,548 |
1,386 |
$190K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,006 |
6,984 |
$176K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,630 |
2,116 |
$156K |
| 81001 |
|
6,594 |
5,757 |
$114K |
| 80053 |
Comprehensive metabolic panel |
12,446 |
10,077 |
$108K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,282 |
2,829 |
$99K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,723 |
5,077 |
$94K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,179 |
959 |
$82K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
813 |
702 |
$44K |
| 71046 |
Radiologic examination, chest; 2 views |
2,167 |
1,972 |
$35K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,546 |
1,303 |
$34K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,675 |
1,455 |
$34K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
840 |
758 |
$30K |
| 84703 |
|
2,260 |
2,002 |
$24K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,796 |
2,079 |
$19K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
604 |
587 |
$17K |
| 87400 |
|
428 |
398 |
$15K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,161 |
1,058 |
$14K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
305 |
277 |
$13K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
243 |
221 |
$13K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,419 |
2,954 |
$11K |
| 93296 |
|
357 |
348 |
$11K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,094 |
1,016 |
$9K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,187 |
4,365 |
$9K |
| 85610 |
|
1,817 |
1,450 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
2,619 |
2,253 |
$9K |
| 87077 |
|
809 |
676 |
$7K |
| 81003 |
|
1,145 |
950 |
$7K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
211 |
201 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
190 |
173 |
$5K |
| 82565 |
|
42 |
38 |
$4K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
80 |
65 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,720 |
9,989 |
$3K |
| 82948 |
|
12 |
12 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,404 |
1,266 |
$2K |
| 86850 |
|
489 |
422 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
490 |
436 |
$2K |
| 85027 |
|
1,918 |
1,585 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,113 |
942 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
68 |
66 |
$1K |
| 82947 |
|
124 |
69 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
51 |
48 |
$1K |
| 84484 |
|
4,978 |
2,903 |
$1K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
785 |
661 |
$1K |
| 87081 |
|
30 |
29 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,158 |
1,948 |
$1K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
120 |
115 |
$901.98 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,359 |
1,944 |
$856.20 |
| 83735 |
|
1,144 |
868 |
$839.03 |
| 84702 |
|
1,244 |
1,016 |
$623.48 |
| 80061 |
Lipid panel |
1,191 |
1,077 |
$592.87 |
| G0378 |
Hospital observation service, per hour |
57 |
24 |
$591.26 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13 |
13 |
$342.80 |
| 83615 |
|
194 |
135 |
$292.95 |
| 83880 |
|
1,175 |
1,023 |
$279.54 |
| 87070 |
|
12 |
12 |
$272.16 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
267 |
243 |
$268.57 |
| 86780 |
|
41 |
41 |
$237.83 |
| 82607 |
|
187 |
166 |
$195.47 |
| 87631 |
|
330 |
315 |
$179.27 |
| 83690 |
|
3,505 |
3,058 |
$176.59 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13 |
13 |
$167.16 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
14 |
12 |
$136.60 |
| 84439 |
|
56 |
50 |
$108.86 |
| 86900 |
|
859 |
743 |
$107.47 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,637 |
1,450 |
$72.73 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,445 |
1,229 |
$53.57 |
| 86140 |
|
57 |
43 |
$31.67 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
681 |
551 |
$30.08 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
737 |
660 |
$25.00 |
| 86901 |
|
861 |
745 |
$22.63 |
| 85730 |
|
386 |
358 |
$7.60 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,858 |
1,553 |
$7.38 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
522 |
451 |
$5.90 |
| 87186 |
|
690 |
604 |
$5.37 |
| 81025 |
|
45 |
38 |
$3.00 |
| 84100 |
|
384 |
289 |
$2.71 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
920 |
732 |
$0.00 |
| 83605 |
|
353 |
246 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
777 |
640 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
486 |
380 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
30 |
28 |
$0.00 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
56 |
39 |
$0.00 |
| 82746 |
|
12 |
12 |
$0.00 |
| 36000 |
|
18 |
14 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
14 |
13 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
18 |
12 |
$0.00 |
| 96376 |
|
55 |
25 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
14 |
12 |
$0.00 |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
28 |
12 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
22 |
14 |
$0.00 |
| 84550 |
|
256 |
184 |
$0.00 |
| 76937 |
|
114 |
93 |
$0.00 |
| 82570 |
|
18 |
16 |
$0.00 |
| 82805 |
|
14 |
12 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
20 |
12 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
47 |
42 |
$0.00 |